Brief: Rubius Therapeutics Shares Open About 33 Pct Above IPO Price In Debut
18/07/2018 15:46
July 18 (Reuters) -
* RUBIUS THERAPEUTICS SHARES OPEN AT $30.51 IN DEBUT ON
NASDAQ
VERSUS IPO PRICE OF $23/SHARE
Further company coverage: RUBY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rubius Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Apple, TCR2 Therapeutics, Silvergate Capital
Brief: Rubius Therapeutics Inc - Nasdaq Notified Co That Trading In Co's Stock Will Be Suspended Upon Opening Of Business On March 7, 2023
Brief: Rubius Therapeutics Board Of Directors Approved Plan Of Liquidation And Dissolution Of Company
Rubius Therapeutics Inc expected to post a loss of 30 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Baidu, Boeing, Microsoft